Watching now and interesting Jon said NNZ-2591 P2 trials planned to commence in next couple of months. Once they file the IND's the FDA have 30 days to review and make comment. Must mean we will be finling them in the next 4 weeks at the latest then straight into trials. Exciting times!
- Forums
- ASX - By Stock
- NEU
- Ann: Notification of investor webinar
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.40%
!
$13.03

Ann: Notification of investor webinar, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.03 |
Change
0.180(1.40%) |
Mkt cap ! $1.628B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.92 | $5.515M | 420.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4 | $13.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.04 | 585 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 1030 | 13.080 |
9 | 877 | 13.070 |
18 | 1726 | 13.060 |
16 | 5116 | 13.050 |
6 | 1373 | 13.040 |
Price($) | Vol. | No. |
---|---|---|
13.100 | 1358 | 14 |
13.110 | 1519 | 16 |
13.120 | 1684 | 17 |
13.130 | 1620 | 11 |
13.140 | 1425 | 5 |
Last trade - 14.26pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online